Can expanded use of oncology biosimilar agents and supportive care agents help support the CMS' value-based care efforts?
Naveed Saleh, MD, MS
The authors of a European review provide recommendations for all stakeholders on smooth implementation of cancer biosimilar agents.
A new study in Cancer Research evaluated the function of TRIM29 in regulating keratin distribution and migration/invasion of SCC.
In an interview with Cancer Network, Brad S. Kahl, MD, weighs in on the top CLL research presented at ASH 2018 in San Diego.
Researchers compared the ability of a novel prognostic score vs existing scores to identify patients with high-risk DLBCL.
The performance of three international guidelines in detecting thryoid cancer was compared based on their sensitivity and fine-needle aspiration rates.
The authors looked at whether rates of malignancy and false-negative fine-needle aspiration results are heightened in large thyroid nodules.
Researchers evaluated the efficacy of 5-florouracil vs imiquimod in preventing site-specific keratinocyte carcinoma.
Results of a study evaluating the safety and efficacy of a promising new agent were presented at ASH 2018.
Research presented at ASH 2018 examined whether checkpoint blockade therapy sensitizes patients with relapsed/refractory NHL to consequent treatment.